AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36059410 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing measures and health education (control group)
Number of subjects: 56
Study 34117621 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved LDL-C targets
Number of subjects: 1521
Study 34117621 — intervention group
Group type: COMPARATOR
Intervention: Not achieving LDL-C targets
Number of subjects: 1521
Study 32770972 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (loading dose of 20,000 or 40,000 IU daily for the first 11 days, followed by a maintenance dose of 2000 IU daily)
Number of subjects: 456
Study 32770972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study 33752070 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg ASTA
Number of subjects: 450
Study 33752070 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 and 80 mg/kg ASTA
Number of subjects: 450
Study 33752070 — intervention group
Group type: COMPARATOR
Intervention: 0 mg/kg ASTA (Control)
Number of subjects: 450
Study 32836109 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1152
Study 32836109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1152
Study 32836109 — intervention group
Group type: COMPARATOR
Intervention: Medical care as usual (CAU)
Number of subjects: 1152
Study 32836109 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (Escitalopram)
Number of subjects: 1152
Study 35361992 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with 10 TCID50 of wild-type SARS-CoV-2 virus
Number of subjects: 36
Study 34324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic explanation
Number of subjects: 545
Study 34324910 — intervention group
Group type: COMPARATOR
Intervention: Environmental explanation
Number of subjects: 545
Study 34324910 — intervention group
Group type: COMPARATOR
Intervention: No label/description
Number of subjects: 545
Study 34324910 — intervention group
Group type: COMPARATOR
Intervention: Polycystic ovary syndrome label
Number of subjects: 545
Study 34324910 — intervention group
Group type: COMPARATOR
Intervention: Weight label
Number of subjects: 545
Study 35091847 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group (lecture using VR images)
Number of subjects: 60
Study 35091847 — intervention group
Group type: COMPARATOR
Intervention: 3D group (lecture using 3D images)
Number of subjects: 60
Study 32589512 — intervention group
Group type: EXPERIMENTAL
Intervention: Research priority areas identified by the Delphi process
Number of subjects: 66
Study 32739671 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured limbs-exercise program (24 weeks, 3 supervised sessions/week for the first 12 weeks, 3 unsupervised sessions/week for the following 12 weeks)
Number of subjects: 116
Study 32739671 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured limbs-exercise program
Number of subjects: 116
Study 32739671 — intervention group
Group type: COMPARATOR
Intervention: Health promotion classes alone
Number of subjects: 116
Study 35521002 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical service intervention
Number of subjects: 190
Study 35521002 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 190
Study 34987595 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Acupuncture Treatment (CAT) group - 5 times/week for 4 weeks
Number of subjects: 72
Study 34987595 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Acupuncture Treatment (IAT) group - 3 times/week for 4 weeks
Number of subjects: 72
Study 34987595 — intervention group
Group type: COMPARATOR
Intervention: Control group - no acupuncture, received routine rehabilitation training
Number of subjects: 72
Study 32303198 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP-counselling offered by trained nurses
Number of subjects: 960
Study 32303198 — intervention group
Group type: COMPARATOR
Intervention: Optimised usual care
Number of subjects: 960
Study 35565886 — intervention group
Group type: EXPERIMENTAL
Intervention: Shelf tag intervention in seven Australian supermarkets
Number of subjects: 0
Study 35565886 — intervention group
Group type: EXPERIMENTAL
Intervention: Shelf tag intervention
Number of subjects: 0
Study 33162599 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate infusion at a rate of 0.07 mg kg‐1 min‐1
Number of subjects: 70
Study 33162599 — intervention group
Group type: COMPARATOR
Intervention: Propofol infusion of 0.7 mg kg‐1 min‐1
Number of subjects: 70
Study 35353329 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive revascularization
Number of subjects: 0
Study 35353329 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 0
Study 33620158 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% P. purpureum
Number of subjects: 300
Study 33620158 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% P. purpureum
Number of subjects: 300
Study 33620158 — intervention group
Group type: COMPARATOR
Intervention: Basic commercial diet
Number of subjects: 300
Study 35702925 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-Centred Health Dialogue intervention
Number of subjects: 1197
Study 35702925 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 1197
Study 33743292 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g protein/kg body weight (BW)/d
Number of subjects: 42
Study 33743292 — intervention group
Group type: COMPARATOR
Intervention: 1.2 g protein/kg BW/d (standard group)
Number of subjects: 42
Study 33743292 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 42
Study 33743292 — intervention group
Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 42
Study 33743292 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 34999806 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation
Number of subjects: 0
Study 34999806 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement
Number of subjects: 0
Study 33616345 — intervention group
Group type: EXPERIMENTAL
Intervention: GDM group
Number of subjects: 72
Study 33616345 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 34838305 — intervention group
Group type: EXPERIMENTAL
Intervention: NaCl (twice/day application for 5 days by caregiver)
Number of subjects: 64
Study 34838305 — intervention group
Group type: COMPARATOR
Intervention: CuSO4 (single application by clinician)
Number of subjects: 64
Study 32872064 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led program (standard care plus telehealth intervention including inquiring about medical condition, providing feedback, counseling, and emotional support)
Number of subjects: 0
Study 32872064 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 34031451 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (assumed increase of 20 nmol/L in 25OHD)
Number of subjects: 1000
Study 32101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab 125 mg every 4 weeks
Number of subjects: 280
Study 32101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab 250 mg every 4 weeks
Number of subjects: 280
Study 32101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab 250 mg every 2 weeks
Number of subjects: 280
Study 32101256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 32101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab (high-dose)
Number of subjects: 280
Study 32101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Number of subjects: 280
Study 36473395 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 500
Study 36473395 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up infarct volume (FIV)
Number of subjects: 500
Study 34077457 — intervention group
Group type: EXPERIMENTAL
Intervention: Click-based echolocation training over 20 sessions in 10 weeks
Number of subjects: 0
Study 34077457 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up survey for blind participants
Number of subjects: 0
Study 32975061 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT13107
Number of subjects: 192
Study 32975061 — intervention group
Group type: COMPARATOR
Intervention: Hyalobarrier®
Number of subjects: 192
Study 35188581 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg loading (three monthly loading doses)
Number of subjects: 0
Study 35188581 — intervention group
Group type: COMPARATOR
Intervention: Brolucizumab 6 mg non-loading (one initial injection)
Number of subjects: 0
Study 33668789 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartwatch-assisted CPR
Number of subjects: 36
Study 33668789 — intervention group
Group type: COMPARATOR
Intervention: Non-smartwatch-assisted CPR
Number of subjects: 36
Study 32861442 — intervention group
Group type: COMPARATOR
Intervention: Global (GB) medium
Number of subjects: 820
Study 32861442 — intervention group
Group type: EXPERIMENTAL
Intervention: G-TL medium
Number of subjects: 820
Study 35108217 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane dressing
Number of subjects: 70
Study 35108217 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurazone-impregnated dressing
Number of subjects: 70
Study 32147955 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (PDE5 inhibitor)
Number of subjects: 50
Study 32147955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35227250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-free and concentrated ascites reinfusion therapy (CART)
Number of subjects: 20
Study 35227250 — intervention group
Group type: COMPARATOR
Intervention: Simple paracentesis (Control)
Number of subjects: 20
Study 32384527 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized wound care order set
Number of subjects: 21
Study 32384527 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-change)
Number of subjects: 21
Study 34664874 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week nurse-led stroke self-management programme (SSMP)
Number of subjects: 64
Study 34464996 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic VSL#3
Number of subjects: 30
Study 34464996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33444120 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise intervention (aerobic/resistance 3×/wk, starting at ∼13th gestation week until birth)
Number of subjects: 80
Study 33444120 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 80
Study 33444120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 80
Study 33491383 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐day‐old biofilm
Number of subjects: 23
Study 33491383 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐day‐old biofilm
Number of subjects: 23
Study 33491383 — intervention group
Group type: COMPARATOR
Intervention: no biofilm (control)
Number of subjects: 23
Study 35706479 — intervention group
Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 31
Study 35706479 — intervention group
Group type: COMPARATOR
Intervention: standard care (Control)
Number of subjects: 31
Study 33975590 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-friendly discharge letter (PFDL)
Number of subjects: 74
Study 33975590 — intervention group
Group type: COMPARATOR
Intervention: Conventional discharge letter (CDL)
Number of subjects: 74
Study 35183134 — intervention group
Group type: EXPERIMENTAL
Intervention: Food literacy and physical activity intervention consisting of five interactive group sessions, 150 min each, including infographics, vegetable recipes, and personalized goals.
Number of subjects: 0
Study 35373003 — intervention group
Group type: EXPERIMENTAL
Intervention: TAKE (taking BP medications as prescribed)
Number of subjects: 131
Study 35373003 — intervention group
Group type: COMPARATOR
Intervention: HOLD (holding BP medications dosed more than once daily)
Number of subjects: 131
Study 32393654 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin (IA) with bone marrow mononuclear cells (MNCs)
Number of subjects: 100
Study 32393654 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular atorvastatin (RA) with bone marrow mononuclear cells (MNCs)
Number of subjects: 100
Study 32393654 — intervention group
Group type: COMPARATOR
Intervention: Intensive atorvastatin (IA) with placebo
Number of subjects: 100
Study 32393654 — intervention group
Group type: COMPARATOR
Intervention: Placebo with bone marrow mononuclear cells (MNCs)
Number of subjects: 100
Study 32393654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32075667 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied while participants paid attention to the FDI muscle
Number of subjects: 33
Study 32075667 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied while participants paid attention to the sound
Number of subjects: 33
Study 32075667 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied without attention to FDI muscle or sound
Number of subjects: 33
Study 32075667 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tDCS and attention to the APB muscle
Number of subjects: 33
Study 35134768 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive suspension system 'Levitas' (Technomex, Poland)
Number of subjects: 85
Study 35134768 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation measures (control group)
Number of subjects: 85
Study 32711530 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge, attitudes, and practices survey regarding cervical cancer and HPV screening
Number of subjects: 679
Study 32711530 — intervention group
Group type: COMPARATOR
Intervention: Knowledge of cervical cancer and HPV screening
Number of subjects: 679
Study 33571532 — intervention group
Group type: EXPERIMENTAL
Intervention: Giant vacuoles (GVs) with I‐pores in high-flow areas
Number of subjects: 2
Study 33571532 — intervention group
Group type: EXPERIMENTAL
Intervention: Giant vacuoles (GVs) with I‐pores
Number of subjects: 2
Study 34426552 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent training program (daily activities, dancing, gardening, sports/games) twice weekly for 3 months
Number of subjects: 63
Study 34426552 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 63
Study 33769656 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin 5 mg
Number of subjects: 483
Study 33769656 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg
Number of subjects: 483
Study 33769656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study 33769656 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin 5 mg and 10 mg
Number of subjects: 483
Study 32876488 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal variant rs3219175 in the promoter region of RETN
Number of subjects: 5621
Study 32876488 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization analyses
Number of subjects: 5621
Study 35972485 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC) for 10 to 14 days as an adjunct to guideline-based treatment (n=922)
Number of subjects: 1893
Study 35972485 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based treatment alone (Control group, n=971)
Number of subjects: 1893
Study 35972485 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC)
Number of subjects: 1893
Study 35972485 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based treatment alone (Control group)
Number of subjects: 1893
Study 34174137 — intervention group
Group type: EXPERIMENTAL
Intervention: Music during flexible cystoscopy
Number of subjects: 109
Study 32315696 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS delivered at Fp3 site for 10 minutes at 1.5 mA
Number of subjects: 112
Study 32315696 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 112
Study 32315696 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 112
Study 34654603 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 22
Study 34654603 — intervention group
Group type: COMPARATOR
Intervention: Control (no piezocision)
Number of subjects: 22
Study 34146045 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal hyperreflective material (SHRM)
Number of subjects: 207
Study 34146045 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF therapy with SHRM
Number of subjects: 207
Study 34146045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SHRM)
Number of subjects: 207
Study 33090112 — intervention group
Group type: EXPERIMENTAL
Intervention: CAir Desk and hybrid digital coaching intervention for 12 weeks
Number of subjects: 0
Study 33090112 — intervention group
Group type: COMPARATOR
Intervention: CAir Desk with usual care for 12 weeks
Number of subjects: 0
Study 34709526 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable
Number of subjects: 208
Study 34709526 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant
Number of subjects: 208
Study 34709526 — intervention group
Group type: EXPERIMENTAL
Intervention: Pills
Number of subjects: 208
Study 34709526 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoms
Number of subjects: 208
Study 34709526 — intervention group
Group type: EXPERIMENTAL
Intervention: No contraception
Number of subjects: 208
Study 34709526 — intervention group
Group type: COMPARATOR
Intervention: No method
Number of subjects: 208
Study 34709526 — intervention group
Group type: COMPARATOR
Intervention: Sterilization
Number of subjects: 208
Study 34709526 — intervention group
Group type: COMPARATOR
Intervention: Natural family planning
Number of subjects: 208
Study 34709526 — intervention group
Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 208
Study 34709526 — intervention group
Group type: COMPARATOR
Intervention: Unknown
Number of subjects: 208
Study 33970955 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 984
Study 33970955 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP)
Number of subjects: 984
Study 33970955 — intervention group
Group type: COMPARATOR
Intervention: Admission timing
Number of subjects: 984
Study 33970955 — intervention group
Group type: COMPARATOR
Intervention: Initial C-reactive protein (CRP) value
Number of subjects: 984
Study 33207359 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine and Midazolam
Number of subjects: 80
Study 33207359 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 80
Study 34164944 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg IV plus standard therapy
Number of subjects: 448
Study 34164944 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 448
Study 33792001 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial excision of the infrapatellar fat pad (IPFP)
Number of subjects: 72
Study 33792001 — intervention group
Group type: COMPARATOR
Intervention: Total excision of the infrapatellar fat pad (IPFP)
Number of subjects: 72
Study 33792001 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (total and partial excision)
Number of subjects: 72
Study 32046597 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-stigmatizing message
Number of subjects: 0
Study 32046597 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 0
Study 35067488 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hour sleep condition
Number of subjects: 16
Study 35067488 — intervention group
Group type: COMPARATOR
Intervention: 7-hour sleep condition
Number of subjects: 16
Study 33314310 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA) interventions, tailored and supervised, varying in type, intensity, duration, and frequency.
Number of subjects: 18
Study 33314310 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to physical activity (PA)
Number of subjects: 18
Study 33314310 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred forms of PA interventions
Number of subjects: 18
Study 33314310 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint self-instructed and group accompanying PA
Number of subjects: 18
Study 33314310 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impact of PA on ABC patients
Number of subjects: 18
Study 33977619 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of medications during pregnancy (multivitamins, analgesics, folic acid)
Number of subjects: 434
Study 33977619 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge acquisition from healthcare providers
Number of subjects: 434
Study 33977619 — intervention group
Group type: EXPERIMENTAL
Intervention: Information provided by pharmacists
Number of subjects: 434
Study 33977619 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes towards medication use during pregnancy
Number of subjects: 434
Study 33977619 — intervention group
Group type: EXPERIMENTAL
Intervention: Association between nationality and occupation with attitudes about medications
Number of subjects: 434
Study 32861359 — intervention group
Group type: EXPERIMENTAL
Intervention: AQE + DWR
Number of subjects: 54
Study 32861359 — intervention group
Group type: COMPARATOR
Intervention: AQE
Number of subjects: 54
Study 36455035 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training (storage and processing or relational integration)
Number of subjects: 171
Study 36455035 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 171
Study 36455035 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 171
Study 33250271 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Concerns Inventory (PCI) fatigue group
Number of subjects: 140
Study 33250271 — intervention group
Group type: COMPARATOR
Intervention: Patients with advanced tumors
Number of subjects: 140
Study 33250271 — intervention group
Group type: COMPARATOR
Intervention: Patients treated with radiotherapy ± chemotherapy
Number of subjects: 140
Study 33914418 — intervention group
Group type: EXPERIMENTAL
Intervention: Online e-learning module
Number of subjects: 0